The multi-factorial nature of clinical multidrug resistance in cancer-Reference-Cited by-同舟云学术

The multi-factorial nature of clinical multidrug resistance in cancer

Published:2019-09 Issue: Volume:46 Page:100645
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Assaraf Yehuda G.,Brozovic Anamaria,Gonçalves Ana Cristina,Jurkovicova Dana,Linē Aija,Machuqueiro Miguel,Saponara Simona,Sarmento-Ribeiro Ana Bela,Xavier Cristina P.R.,Vasconcelos M. Helena

Funder

COST

Croatian Science Foundation

Scientific Grant Agency VEGA of Slovak Republic

Slovak Research and Development Agency

Ministry of Education, Science Research and Sport of Slovak Republic

Latvian Council of Science

Fundação para a Ciência e Tecnologia

Italian Ministry of University and Research

Foundation for Science and Technology

FEDER

European Regional Development Fund

Norte Portugal Regional Programme

FCT

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference532 articles.

1. Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects;Abbas;Drug Metab. Pers. Ther.,2015

2. Epigenetic therapy in gastrointestinal cancer: the right combination;Abdelfatah;Therap. Adv. Gastroenterol.,2016

3. Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers;Adar;Cell Death Dis.,2012

4. Epigenetic therapeutics: a new weapon in the war against Cancer;Ahuja;Annu. Rev. Med.,2016

5. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients;Aktas;Breast Cancer Res.,2009

Cited by 378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential;Non-coding RNA Research;2024-12

2. Phosphatidylserine-targeting bis(zinc-dipicolylamine) farnesol inhibits ATP production in cancer cells to overcome multidrug resistance;Supramolecular Materials;2024-12

3. STAT3-specific nanocarrier for shRNA/drug dual delivery and tumor synergistic therapy;Bioactive Materials;2024-11

4. UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling;Redox Biology;2024-10

5. Plant-Based Products Originating from Serbia That Affect P-glycoprotein Activity;Molecules;2024-09-11